Accès gratuit
Volume 25, Juillet 2016
Médecine interne et transversalité
Page(s) S137 - S149
Section Mise au Point / Update
Publié en ligne 22 juin 2016
  • Schuppan D, Afdhal NH (2008) Liver cirrhosis. Lancet 371:838–51 [CrossRef] [PubMed] [Google Scholar]
  • Nadim MK, Durand F, Kellum JA, et al (2016) Management of the critically ill patient with cirrhosis: A multidisciplinary perspective. J Hepatol 64:717–35 [CrossRef] [PubMed] [Google Scholar]
  • Papadakis MA, Arieff AI (1987) Unpredictability of clinical evaluation of renal function in cirrhosis. Prospective study. Am J Med 82:945–52 [CrossRef] [PubMed] [Google Scholar]
  • Wong F, Nadim MK, Kellum JA, et al (2011) Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut 60:702–9 [CrossRef] [PubMed] [Google Scholar]
  • Beben T, Rifkin DE (2015) GFR Estimating Equations and Liver Disease. Adv Chronic Kidney Dis 22:337–42 [CrossRef] [PubMed] [Google Scholar]
  • Herget-Rosenthal S, Bokenkamp AHofmann W (2007) How to estimate GFR-serum creatinine, serum cystatin C or equations? Clin Biochem 40:153–61 [CrossRef] [PubMed] [Google Scholar]
  • Davenport A (2011) Difficulties in assessing renal function in patients with cirrhosis: potential impact on patient treatment. Intensive Care Med 37:930–2 [CrossRef] [PubMed] [Google Scholar]
  • Mindikoglu AL, Dowling TC, Weir MR, et al (2014) Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis. Hepatology 59:1532–42 [CrossRef] [PubMed] [Google Scholar]
  • Caregaro L, Menon F, Angeli P, et al (1994) Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. Arch Intern Med 154:201–5 [CrossRef] [PubMed] [Google Scholar]
  • Waikar SS, Bonventre JV (2009) Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol 20:672–9 [CrossRef] [PubMed] [Google Scholar]
  • Davenport A, Cholongitas E, Xirouchakis E, et al (2011) Pitfalls in assessing renal function in patients with cirrhosis--potential inequity for access to treatment of hepatorenal failure and liver transplantation. Nephrol Dial Transplant 26:2735–42 [CrossRef] [PubMed] [Google Scholar]
  • Spencer K (1986) Analytical reviews in clinical biochemistry: the estimation of creatinine. Ann Clin Biochem 23:1–25 [CrossRef] [PubMed] [Google Scholar]
  • Francoz C, Glotz D, Moreau R, et al (2010) The evaluation of renal function and disease in patients with cirrhosis. J Hepatol 52:605–13 [CrossRef] [PubMed] [Google Scholar]
  • Soveri I, Berg UB, Bjork J, et al (2014) Measuring GFR: a systematic review. Am J Kidney Dis 64:411–24 [CrossRef] [PubMed] [Google Scholar]
  • Chen YW, Chang CW, Chang CW, et al (2012) Is an estimated glomerular filtration rate better than creatinine to be incorporated into the end-stage liver disease score? World J Hepatol 4:291–8 [CrossRef] [PubMed] [Google Scholar]
  • Francoz C, Nadim MK, Baron A, et al (2014) Glomerular filtration rate equations for liver-kidney transplantation in patients with cirrhosis: validation of current recommendations. Hepatology 59:1514–21 [CrossRef] [PubMed] [Google Scholar]
  • Zahran A, El-Husseini A, Shoker A (2007) Can cystatin C replace creatinine to estimate glomerular filtration rate? A literature review. Am J Nephrol 27:197–205 [CrossRef] [PubMed] [Google Scholar]
  • Stevens LA, Schmid CH, Greene T, et al (2009) Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 75:652–60 [CrossRef] [PubMed] [Google Scholar]
  • Ladero JM, Cardenas MC, Ortega L, et al (2012) Serum cystatin C: a non-invasive marker of liver fibrosis or of current liver fibrogenesis in chronic hepatitis C? Ann Hepatol 11:648–51 [PubMed] [Google Scholar]
  • Omar M, Abdel-Razek W, Abo-Raia G, et al (2015) Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis. Int J Hepatol 2015:309042 [CrossRef] [PubMed] [Google Scholar]
  • Krones E, Fickert P, Zitta S, et al (2015) The chronic kidney disease epidemiology collaboration equation combining creatinine and cystatin C accurately assesses renal function in patients with cirrhosis. BMC Nephrol 16:196 [CrossRef] [PubMed] [Google Scholar]
  • Torre A, Aguirre-Valadez JM, Arreola-Guerra JM, et al (2016) Creatinine Versus Cystatin C for Estimating GFR in Patients With Liver Cirrhosis. Am J Kidney Dis 67:342–4 [CrossRef] [Google Scholar]
  • Inker LA, Schmid CH, Tighiouart H, et al (2012) Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367:20–9 [CrossRef] [PubMed] [Google Scholar]
  • Mindikoglu AL, Dowling TC, Magder LS, et al (2016) Estimation of Glomerular Filtration Rate in Patients With Cirrhosis by Using New and Conventional Filtration Markers and Dimethylarginines. Clin Gastroenterol Hepatol 14: 624–32.e2wegh [CrossRef] [PubMed] [Google Scholar]
  • Gonzalez F, Vincent F (2012) Biomarkers for acute kidney injury in critically ill patients. Minerva Anestesiol 78:1394–403 [PubMed] [Google Scholar]
  • Gungor G, Ataseven H, Demir A, et al (2014) Neutrophil gelatinase-associated lipocalin in prediction of mortality in patients with hepatorenal syndrome: a prospective observational study. Liver Int 34:49–57 [CrossRef] [PubMed] [Google Scholar]
  • Platt JF, Ellis JH, Rubin JM, et al (1994) Renal duplex Doppler ultrasonography: a noninvasive predictor of kidney dysfunction and hepatorenal failure in liver disease. Hepatology 20:362–9 [CrossRef] [PubMed] [Google Scholar]
  • Platt JF, Marn CS, Baliga PK, et al (1992) Renal dysfunction in hepatic disease: early identification with renal duplex Doppler US in patients who undergo liver transplantation. Radiology 183:801–6 [CrossRef] [PubMed] [Google Scholar]
  • Culafic D, Stulic M, Obrenovic R, et al (2014) Role of cystatin C and renal resistive index in assessment of renal function in patients with liver cirrhosis. World J Gastroenterol 20:6573–9 [CrossRef] [PubMed] [Google Scholar]
  • Vivier PH, Storey P, Rusinek H, et al (2011) Kidney function: glomerular filtration rate measurement with MR renography in patients with cirrhosis. Radiology 259:462–70 [CrossRef] [PubMed] [Google Scholar]
  • Poreddy AR, Neumann WL, Freskos JN, et al (2012) Exogenous fluorescent tracer agents based on pegylated pyrazine dyes for real-time point-of-care measurement of glomerular filtration rate. Bioorg Med Chem 20:2490–7 [CrossRef] [PubMed] [Google Scholar]
  • Charlton MR, Wall WJ, Ojo AO, et al (2009) Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation. Liver Transpl 15:S1–34 [CrossRef] [Google Scholar]
  • du Cheyron D, Bouchet B, Parienti JJ, et al (2005) The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis. Intensive Care Med 31:1693–9 [CrossRef] [PubMed] [Google Scholar]
  • Belcher JM, Garcia-Tsao G, Sanyal AJ, et al (2013) Association of AKI with mortality and complications in hospitalized patients with cirrhosis. Hepatology 57:753–62 [CrossRef] [PubMed] [Google Scholar]
  • Khwaja A (2012) KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 120:c179–184 [CrossRef] [PubMed] [Google Scholar]
  • National Kidney F (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1–266 [PubMed] [Google Scholar]
  • Choi YJ, Kim JH, Koo JK, et al (2014) Prevalence of renal dysfunction in patients with cirrhosis according to ADQI-IAC working party proposal. Clin Mol Hepatol 20:185–91 [CrossRef] [PubMed] [Google Scholar]
  • De Silva ST, Perera RP, Niriella MA, et al (2014) Frequency, pattern and short-term outcome of chronic renal dysfunction in patients with cirrhosis: a prospective study using HRS and ADQI-IAC criteria. Eur J Gastroenterol Hepatol 26:1296–9 [CrossRef] [PubMed] [Google Scholar]
  • Salerno F, Gerbes A, Gines P, et al (2007) Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 56:1310–8 [PubMed] [Google Scholar]
  • Angeli P, Gines P, Wong F, et al (2015) Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. J Hepatol 62:968–74 [CrossRef] [PubMed] [Google Scholar]
  • Cavallin M, Piano S, Romano A, et al (2016) Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study. Hepatology 63:983–92 [CrossRef] [PubMed] [Google Scholar]
  • Gonwa TA, Jennings L, Mai ML, et al (2004) Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl 10:301–9 [CrossRef] [PubMed] [Google Scholar]
  • Saxena V, Lai JC (2015) Kidney Failure and Liver Allocation: Current Practices and Potential Improvements. Adv Chronic Kidney Dis 22:391–8 [CrossRef] [PubMed] [Google Scholar]
  • Cholongitas E, Marelli L, Kerry A, et al (2007) Different methods of creatinine measurement significantly affect MELD scores. Liver Transpl 13:523–9 [CrossRef] [PubMed] [Google Scholar]
  • Puri V, Eason J (2015) Simultaneous Liver-Kidney Transplantation. Curr Transplant Rep 2:297–302 [CrossRef] [PubMed] [Google Scholar]
  • Ruebner R, Goldberg D, Abt PL, et al (2012) Risk of end-stage renal disease among liver transplant recipients with pretransplant renal dysfunction. Am J Transplant 12:2958–65 [CrossRef] [PubMed] [Google Scholar]
  • Nadim MK, Sung RS, Davis CL, et al (2012) Simultaneous liver-kidney transplantation summit: current state and future directions. Am J Transplant 12:2901–8 [CrossRef] [PubMed] [Google Scholar]
  • Urrunaga NH, Mindikoglu AL, Rockey DC (2015) Renal dysfunction in cirrhosis. Curr Opin Gastroenterol 31:215–23 [CrossRef] [PubMed] [Google Scholar]
  • Rognant N, Lemoine S (2014) Evaluation of renal function in patients with cirrhosis: where are we now? World J Gastroenterol 20:2533–41 [CrossRef] [PubMed] [Google Scholar]
  • Roy L, Legault L, Pomier-Layrargues G (1998) Glomerular filtration rate measurement in cirrhotic patients with renal failure. Clin Nephrol 50:342–6 [PubMed] [Google Scholar]
  • Demirtas S, Bozbas A, Akbay A, et al (2001) Diagnostic value of serum cystatin C for evaluation of hepatorenal syndrome. Clin Chim Acta 311:81–9 [CrossRef] [PubMed] [Google Scholar]
  • Orlando R, Floreani M, Padrini R, et al (1999) Evaluation of measured and calculated creatinine clearances as glomerular filtration markers in different stages of liver cirrhosis. Clin Nephrol 51:341–7 [PubMed] [Google Scholar]
  • Woitas RP, Stoffel-Wagner B, Flommersfeld S, et al (2000) Correlation of serum concentrations of cystatin C and creatinine to inulin clearance in liver cirrhosis. Clin Chem 46:712–5 [PubMed] [Google Scholar]
  • Orlando R, Mussap M, Plebani M, et al (2002) Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin Chem 48:850–8 [PubMed] [Google Scholar]
  • Poge U, Gerhardt T, Stoffel-Wagner B, et al (2006) Calculation of glomerular filtration rate based on cystatin C in cirrhotic patients. Nephrol Dial Transplant 21:660–4 [CrossRef] [PubMed] [Google Scholar]
  • MacAulay J, Thompson K, Kiberd BA, et al (2006) Serum creatinine in patients with advanced liver disease is of limited value for identification of moderate renal dysfunction: are the equations for estimating renal function better? Can J Gastroenterol 20:521–6 [CrossRef] [PubMed] [Google Scholar]
  • Francoz C, Prie D, Abdelrazek W, et al (2010) Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score. Liver Transpl 16:1169–77 [CrossRef] [PubMed] [Google Scholar]
  • Rognant N, Bacchetta J, Dubourg L, et al (2010) What is the best alternative to inulin clearance to estimate GFR in patients with decompensated alcoholic cirrhosis? Nephrol Dial Transplant 25:3569–75 [CrossRef] [PubMed] [Google Scholar]
  • Kim DJ, Kang HS, Choi HS, et al (2011) Serum cystatin C level is a useful marker for the evaluation of renal function in patients with cirrhotic ascites and normal serum creatinine levels. Korean J Hepatol 17:130–8 [CrossRef] [PubMed] [Google Scholar]
  • Xirouchakis E, Marelli L, Cholongitas E, et al (2011) Comparison of cystatin C and creatinine-based glomerular filtration rate formulas with 51Cr-EDTA clearance in patients with cirrhosis. Clin J Am Soc Nephrol 6:84–92 [CrossRef] [PubMed] [Google Scholar]
  • Gerhardt T, Poge U, Stoffel-Wagner B, et al (2011) Creatinine-based glomerular filtration rate estimation in patients with liver disease: the new Chronic Kidney Disease Epidemiology Collaboration equation is not better. Eur J Gastroenterol Hepatol 23:969–73 [CrossRef] [PubMed] [Google Scholar]
  • De Souza V, Hadj-Aissa A, Dolomanova O, et al (2014) Creatinine- versus cystatine C-based equations in assessing the renal function of candidates for liver transplantation with cirrhosis. Hepatology 59:1522–31 [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.